SHANGHAI – Glaxosmithkline plc has confirmed the company is under investigation by the UK Serious Fraud Office (SFO). The case is presumed to be related to the almost year-long corruption investigation into GSK China activities that came to a close last week. UK's largest drugmaker is facing ever more serious legal troubles in its own backyard as the big pharma and its executives are awaiting trial here.